Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802072

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802072

Global Urinary Incontinence Devices Market Size Study & Forecast, by Product (Urinary Catheters, Artificial Urinary Sphincters), Incontinence Type, Patient Type, End User and Regional Forecasts 2025-2035

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Urinary Incontinence Devices Market is valued at approximately USD 4.22 billion in 2024 and is anticipated to grow at a CAGR of more than 11.20% over the forecast period 2025-2035. Urinary incontinence, an often-overlooked yet highly prevalent condition, has increasingly been brought into the spotlight due to rising awareness, a growing geriatric population, and shifting patient attitudes towards seeking advanced medical solutions. Devices designed to manage urinary incontinence, such as urinary catheters, artificial urinary sphincters, and specialized hospital-based systems, are transforming the quality of life for millions globally. The demand for these devices is being propelled by the rising prevalence of urological disorders, post-surgical complications, and lifestyle changes that exacerbate bladder control issues. In addition, technological innovation in minimally invasive devices and improved patient compliance solutions is reshaping the market landscape, compelling stakeholders to push forward with investments and expansions.

With the rising number of patients suffering from stress incontinence and related bladder dysfunctions, the need for efficient, durable, and patient-friendly devices has surged significantly. According to the International Continence Society, urinary incontinence affects over 200 million people worldwide, with a disproportionate impact on aging women. This growing patient pool has encouraged medical device manufacturers to broaden their portfolios, invest in innovation, and strengthen their presence across hospital networks and clinical practices. Moreover, government support in healthcare infrastructure development, combined with reimbursement policies in several developed economies, has further driven adoption. While the market faces challenges from the social stigma surrounding incontinence and the availability of conservative treatment options, the consistent rise in surgical procedures, coupled with the integration of smart healthcare technologies, opens a fertile ground for growth.

Regionally, North America commanded the largest share of the market in 2024 owing to its advanced healthcare ecosystem, strong presence of leading market players, and growing awareness campaigns focused on women's health and geriatric care. The U.S. in particular continues to spearhead innovation and adoption with robust clinical research, favorable reimbursement policies, and an expanding elderly demographic. Meanwhile, Europe maintains a significant footprint, backed by a high prevalence of incontinence cases and an established network of healthcare providers offering advanced solutions. Asia Pacific, however, is expected to be the fastest-growing region during the forecast period. The surge can be attributed to rapid urbanization, expanding healthcare infrastructure, and a growing patient population in countries like China, India, and Japan. Additionally, shifting social attitudes and increased healthcare expenditure in these regions are fostering demand for urinary incontinence devices. Latin America and the Middle East & Africa also present notable opportunities, albeit at a slower adoption rate, as healthcare modernization gradually expands access to advanced treatments.

Major market players included in this report are:

  • Hollister Incorporated
  • Medtronic plc
  • Boston Scientific Corporation
  • Coloplast A/S
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Djo Global Inc.
  • C.R. Bard, Inc. (A Becton, Dickinson Company)
  • Pfizer Inc.
  • Stryker Corporation
  • ConvaTec Group PLC
  • Roche Holding AG
  • Cook Medical, Inc.
  • Promedon Group
  • Kimberly-Clark Corporation

Global Urinary Incontinence Devices Market Report Scope:

  • Historical Data - 2023, 2024
  • Base Year for Estimation - 2024
  • Forecast period - 2025-2035
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product:

  • Urinary Catheters
  • Indwelling Catheters
  • Intermittent Catheters
  • Artificial Urinary Sphincters

By Incontinence Type:

  • Stress

By Patient Type:

  • Male
  • Female

By End User:

  • Hospitals

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2025 to 2035.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Urinary Incontinence Devices Market Report Scope & Methodology

  • 1.1. Research Objective
  • 1.2. Research Methodology
    • 1.2.1. Forecast Model
    • 1.2.2. Desk Research
    • 1.2.3. Top Down and Bottom-Up Approach
  • 1.3. Research Attributes
  • 1.4. Scope of the Study
    • 1.4.1. Market Definition
    • 1.4.2. Market Segmentation
  • 1.5. Research Assumption
    • 1.5.1. Inclusion & Exclusion
    • 1.5.2. Limitations
    • 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

  • 2.1. CEO/CXO Standpoint
  • 2.2. Strategic Insights
  • 2.3. ESG Analysis
  • 2.4. key Findings

Chapter 3. Global Urinary Incontinence Devices Market Forces Analysis

  • 3.1. Market Forces Shaping The Global Urinary Incontinence Devices Market (2024-2035)
  • 3.2. Drivers
    • 3.2.1. Accelerating geriatric population and rising prevalence of urological disorders
    • 3.2.2. Technological advances in minimally invasive devices and favorable reimbursement adoption
  • 3.3. Restraints
    • 3.3.1. Social stigma, underdiagnosis, and low care-seeking behavior
    • 3.3.2. Complications and risks (e.g., CAUTI) and availability of conservative therapies
  • 3.4. Opportunities
    • 3.4.1. Rapid healthcare modernization and unmet need in Asia Pacific markets
    • 3.4.2. Homecare-centric and connected continence solutions (smart monitoring, telehealth)

Chapter 4. Global Urinary Incontinence Devices Industry Analysis

  • 4.1. Porter's 5 Forces Model
    • 4.1.1. Bargaining Power of Buyer
    • 4.1.2. Bargaining Power of Supplier
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Forecast Model (2024-2035)
  • 4.3. PESTEL Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top Investment Opportunities
  • 4.5. Top Winning Strategies (2025)
  • 4.6. Market Share Analysis (2024-2025)
  • 4.7. Global Pricing Analysis And Trends 2025
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Urinary Incontinence Devices Market Size & Forecasts by Product 2025-2035

  • 5.1. Market Overview
  • 5.2. Global Urinary Incontinence Devices Market Performance - Potential Analysis (2025)
  • 5.3. Urinary Catheters
    • 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.3.2. Market size analysis, by region, 2025-2035
  • 5.4. Artificial Urinary Sphincters
    • 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.4.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Urinary Incontinence Devices Market Size & Forecasts by Patient Type 2025-2035

  • 6.1. Market Overview
  • 6.2. Global Urinary Incontinence Devices Market Performance - Potential Analysis (2025)
  • 6.3. Male
    • 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.3.2. Market size analysis, by region, 2025-2035
  • 6.4. Female
    • 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Urinary Incontinence Devices Market Size & Forecasts by Region 2025-2035

  • 7.1. Urinary Incontinence Devices Market, Regional Market Snapshot
  • 7.2. Top Leading & Emerging Countries
  • 7.3. North America Urinary Incontinence Devices Market
    • 7.3.1. U.S. Urinary Incontinence Devices Market
      • 7.3.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.3.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.3.2. Canada Urinary Incontinence Devices Market
      • 7.3.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.3.2.2. Application breakdown size & forecasts, 2025-2035
  • 7.4. Europe Urinary Incontinence Devices Market
    • 7.4.1. UK Urinary Incontinence Devices Market
      • 7.4.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.2. Germany Urinary Incontinence Devices Market
      • 7.4.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.3. France Urinary Incontinence Devices Market
      • 7.4.3.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.3.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.4. Spain Urinary Incontinence Devices Market
      • 7.4.4.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.4.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.5. Italy Urinary Incontinence Devices Market
      • 7.4.5.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.5.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.6. Rest of Europe Urinary Incontinence Devices Market
      • 7.4.6.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.6.2. Application breakdown size & forecasts, 2025-2035
  • 7.5. Asia Pacific Urinary Incontinence Devices Market
    • 7.5.1. China Urinary Incontinence Devices Market
      • 7.5.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.2. India Urinary Incontinence Devices Market
      • 7.5.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.3. Japan Urinary Incontinence Devices Market
      • 7.5.3.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.3.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.4. Australia Urinary Incontinence Devices Market
      • 7.5.4.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.4.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.5. South Korea Urinary Incontinence Devices Market
      • 7.5.5.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.5.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.6. Rest of APAC Urinary Incontinence Devices Market
      • 7.5.6.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.6.2. Application breakdown size & forecasts, 2025-2035
  • 7.6. Latin America Urinary Incontinence Devices Market
    • 7.6.1. Brazil Urinary Incontinence Devices Market
      • 7.6.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.6.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.6.2. Mexico Urinary Incontinence Devices Market
      • 7.6.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.6.2.2. Application breakdown size & forecasts, 2025-2035
  • 7.7. Middle East and Africa Urinary Incontinence Devices Market
    • 7.7.1. UAE Urinary Incontinence Devices Market
      • 7.7.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.7.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.7.2. Saudi Arabia (KSA) Urinary Incontinence Devices Market
      • 7.7.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.7.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.7.3. South Africa Urinary Incontinence Devices Market
      • 7.7.3.1. Type breakdown size & forecasts, 2025-2035
      • 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Hollister Incorporated
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Financial Performance (Subject to Data Availability)
    • 8.2.5. Product/Services Port
    • 8.2.6. Recent Development
    • 8.2.7. Market Strategies
    • 8.2.8. SWOT Analysis
  • 8.3. Medtronic plc
  • 8.4. Boston Scientific Corporation
  • 8.5. Coloplast A/S
  • 8.6. Teleflex Incorporated
  • 8.7. B. Braun Melsungen AG
  • 8.8. C.R. Bard, Inc. (A Becton, Dickinson Company)
  • 8.9. ConvaTec Group PLC
  • 8.10. Cook Medical, Inc.
  • 8.11. Kimberly-Clark Corporation
  • 8.12. Stryker Corporation
  • 8.13. Roche Holding AG
  • 8.14. Promedon Group
  • 8.15. Djo Global Inc.
  • 8.16. Pfizer Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!